Lactulose Challenge Determines Visceral Sensitivity and Severity of Symptoms in Patients With Irritable Bowel Syndrome  Boris Le Nevé, Rémi Brazeilles,

Slides:



Advertisements
Similar presentations
Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.
Advertisements

Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.
Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis  Alexander C. Ford, Brennan M.R. Spiegel, Nicholas.
Volume 149, Issue 6, Pages e2 (November 2015)
An Unusual Cause of Small Bowel Obstruction: A Plastic Glove
Efficacy of a Gluten-Free Diet in Subjects With Irritable Bowel Syndrome-Diarrhea Unaware of Their HLA-DQ2/8 Genotype  Imran Aziz, Nick Trott, Rebecca.
Abnormal Liver Tests and Fatty Liver on Ultrasound
Saurabh Dawra, Vishal Sharma, Usha Dutta 
Prevalence, Characteristics, and Impact of Bloating Symptoms in Patients With Irritable Bowel Syndrome  Yehuda Ringel, Rachel E. Williams, Linda Kalilani,
Charles D. Gerson, Mary-Joan Gerson 
Patient-Reported Outcomes for Irritable Bowel Syndrome Are Associated With Patients' Severity Ratings of Gastrointestinal Symptoms and Psychological Factors 
Volume 152, Issue 1, Pages e8 (January 2017)
Role of Colonic Fermentation in the Perception of Colonic Distention in Irritable Bowel Syndrome and Functional Bloating  Michele Di Stefano, Emanuela.
Treatment of Esophageal (Noncardiac) Chest Pain: An Expert Review
Shou–Jiang Tang, Feriyl Bhaijee 
Immune Reconstitution Inflammatory Syndrome of the Small Bowel in a Human Immunodeficiency Virus–Negative Patient  Severin Daum, Christoph Loddenkemper,
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis  Anita Sainsbury, David S. Sanders, Alexander C.
Volume 141, Issue 5, Pages (November 2011)
Volume 149, Issue 6, Pages e2 (November 2015)
Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome  Megan Rossi, Raphael Aggio,
Volume 149, Issue 6, Pages e2 (November 2015)
Volume 150, Issue 4, Pages (April 2016)
Eamonn M.M. Quigley  Clinical Gastroenterology and Hepatology 
Partner Burden in Irritable Bowel Syndrome
Prospective Study of Motor, Sensory, Psychologic, and Autonomic Functions in Patients With Irritable Bowel Syndrome  Michael Camilleri, Sanna McKinzie,
Effect of Ramosetron on Stool Consistency in Male Patients With Irritable Bowel Syndrome With Diarrhea  Shin Fukudo, Motoko Ida, Hiraku Akiho, Yoshihiro.
Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study  Henry P. Parkman,
Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis  Alexander C. Ford, Brennan M.R. Spiegel, Nicholas.
An Unusual Cause of Small Bowel Obstruction: A Plastic Glove
Personalizing Colorectal Cancer Screening: A Systematic Review of Models to Predict Risk of Colorectal Neoplasia  Gene K. Ma, Uri Ladabaum  Clinical Gastroenterology.
Atopic Characteristics of Adult Patients With Eosinophilic Esophagitis
Activity-Based Costing and Management in a Hospital-Based GI Unit
Prevalence and Presentation of Lactose Intolerance and Effects on Dairy Product Intake in Healthy Subjects and Patients With Irritable Bowel Syndrome 
Spencer D. Dorn, Carolyn B. Morris, Susan E. Schneck, Teresa M
Cainan Foltz, Williamson Strum 
AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review  Jean-Frederic Colombel,
Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea  Reginald V. Fant,
Millie D. Long, Hans H. Herfarth, Clare A. Pipkin, Carol Q
A Comprehensive Self-Management Irritable Bowel Syndrome Program Produces Sustainable Changes in Behavior After 1 Year  Jasmine K. Zia, Pamela Barney,
Effects of 5-Hydroxytryptamine (Serotonin) Type 3 Antagonists on Symptom Relief and Constipation in Nonconstipated Irritable Bowel Syndrome: A Systematic.
Dietary Triggers of Abdominal Symptoms in Patients With Irritable Bowel Syndrome: Randomized Placebo-Controlled Evidence  Susan J. Shepherd, Francis C.
Abnormal Liver Tests and Fatty Liver on Ultrasound
Effects of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation: A Meta-analysis  Elizabeth J. Videlock, Vivian.
Bara Erhayiem, Rajpal Dhingsa, Christopher J
Efficacy of a Gluten-Free Diet in Subjects With Irritable Bowel Syndrome-Diarrhea Unaware of Their HLA-DQ2/8 Genotype  Imran Aziz, Nick Trott, Rebecca.
Kara Bradford, Wendy Shih, Elizabeth J. Videlock, Angela P
Short-term and Long-term Efficacy of Psychological Therapies for Irritable Bowel Syndrome: A Systematic Review and Meta-analysis  Kelsey T. Laird, Emily.
Amnon Sonnenberg  Clinical Gastroenterology and Hepatology 
Coping Skills Are Associated With Gastrointestinal Symptom Severity and Somatization in Patients With Irritable Bowel Syndrome  Katarina Wilpart, Hans.
Rebecca M. Lovell, Alexander C. Ford 
Volume 145, Issue 3, Pages (September 2013)
Patient-Reported Outcomes and Endoscopic Appearance of Ulcerative Colitis: A Systematic Review and Meta-analysis  Neeraj Narula, Abdul-Aziz Alshahrani,
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Elizabeth Mileti, Philip Rosenthal, Marion G. Peters 
Systematic Review and Meta-analysis of the Prevalence of Irritable Bowel Syndrome in Individuals With Dyspepsia  Alexander C. Ford, Avantika Marwaha,
Risk of Irritable Bowel Syndrome After an Episode of Bacterial Gastroenteritis in General Practice: Influence of Comorbidities  Ana Ruigómez, Luis Alberto.
The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: A double.
Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet 
Issue Highlights Clinical Gastroenterology and Hepatology
Severe irritable bowel and functional abdominal pain syndromes: Managing the patient and health care costs  George F. Longstreth, Douglas A. Drossman 
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Effect of Ramosetron on Stool Consistency in Male Patients With Irritable Bowel Syndrome With Diarrhea  Shin Fukudo, Motoko Ida, Hiraku Akiho, Yoshihiro.
Volume 133, Issue 4, Pages (October 2007)
Erick Alayo, Bashar Attar, Benjamin Go 
GI Bleeding, Colon Varicosities, and Visceral Enlargement as a Manifestation of Klippel– Trenaunay Syndrome  Fnu Deepinder  Clinical Gastroenterology and.
Electronic Clinical Challenges and Images in GI
Adverse Outcomes: Why Bad Things Happen to Good People
Self-Administered Cognitive Behavior Therapy for Moderate to Severe Irritable Bowel Syndrome: Clinical Efficacy, Tolerability, Feasibility  Jeffrey M.
Klaus Mönkemüller, Helmut Neumann, Lucia C. Fry 
Presentation transcript:

Lactulose Challenge Determines Visceral Sensitivity and Severity of Symptoms in Patients With Irritable Bowel Syndrome  Boris Le Nevé, Rémi Brazeilles, Muriel Derrien, Julien Tap, Denis Guyonnet, Lena Ohman, Hans Törnblom, Magnus Simrén  Clinical Gastroenterology and Hepatology  Volume 14, Issue 2, Pages 226-233.e3 (February 2016) DOI: 10.1016/j.cgh.2015.09.039 Copyright © 2016 AGA Institute Terms and Conditions

Figure 1 GI symptom-based IBS clustering and PCA after a 25 g lactulose challenge test. (A) Cluster analysis in IBS subjects (n = 100) was performed by ascending hierarchical clustering based on the 8 meal-related GI symptoms and digestive comfort (4-h mean area under the curve scores for each individual symptom). (B) Score plot of the PCA performed for all IBS patients (n = 100) on the 8 meal-related GI symptoms and digestive comfort as active variables (4-h mean area under the curve scores for each individual symptom). LGS cluster (white dots) and HGS cluster (grey dots). LGS IBS, n = 61; HGS IBS, n = 39. Clinical Gastroenterology and Hepatology 2016 14, 226-233.e3DOI: (10.1016/j.cgh.2015.09.039) Copyright © 2016 AGA Institute Terms and Conditions

Figure 2 Intensity of rectal sensations in IBS clusters during the barostat test. Intensity (visual analog scale, 0–100 mm) of rectal sensations in IBS patients during random phasic distension at 24 mm Hg. Statistical significance was determined by 1-way analysis of variance and Benjamini–Hochberg multiplicity correction. NS for P value > .05, *P < .05, **P < .01, ***P < .001. LGS cluster is shown in white bars, and the HGS cluster is shown in grey bars. LGS IBS, n = 54; HGS IBS, n = 39. Clinical Gastroenterology and Hepatology 2016 14, 226-233.e3DOI: (10.1016/j.cgh.2015.09.039) Copyright © 2016 AGA Institute Terms and Conditions

Figure 3 Fecal microbiota diversity and composition assessed by 16S ribosomal RNA targeted pyrosequencing in IBS clusters. (A) Weighted UniFrac principal coordinate analysis of fecal microbiota from IBS clusters. (B) Microbial richness (Chao1) of fecal microbiota from IBS clusters. (C) Log10 of Firmicutes/Bacteroidetes ratio of fecal microbiota from IBS clusters. LGS cluster is shown by white dots/bars, and HGS cluster is shown by grey dots/bars. LGS IBS, n = 53; HGS IBS, n = 37. Clinical Gastroenterology and Hepatology 2016 14, 226-233.e3DOI: (10.1016/j.cgh.2015.09.039) Copyright © 2016 AGA Institute Terms and Conditions

Supplementary Figure 1 Receiver operating characteristic (ROC) curve for sensation of pain elicited by a combined nutrient and lactulose challenge test vs IBS-SSS score in IBS patients. ROC analysis was conducted to evaluate the capacity of pain elicited by a lactulose challenge test in discriminating severe IBS (IBS-SSS > 300; n = 43) from mild/moderate IBS (IBS-SSS ≤ 300; n = 55). For different values of pain, sensibility and specificity were calculated and plotted on the ROC curve. Clinical Gastroenterology and Hepatology 2016 14, 226-233.e3DOI: (10.1016/j.cgh.2015.09.039) Copyright © 2016 AGA Institute Terms and Conditions

Supplementary Figure 2 Fecal microbiota richness and diversity assessed by 16S ribosomal RNA–targeted pyrosequencing in IBS clusters. Microbial richness (number of operational taxonomic units) and diversity (Shannon) of fecal microbiota from IBS clusters. LGS cluster (white bar) and HGS cluster (grey bar). LGS IBS, n = 53; HGS IBS, n = 37. Clinical Gastroenterology and Hepatology 2016 14, 226-233.e3DOI: (10.1016/j.cgh.2015.09.039) Copyright © 2016 AGA Institute Terms and Conditions